Mettler-Toledo International Reaches New 52-Week High (MTD)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Mettler-Toledo International (NYSE: MTD) hit a new 52-week high Tuesday as it is currently trading at $192.20, above its previous 52-week high of $191.93 with 19,381 shares traded as of 10:30 a.m. ET. Average volume has been 191,400 shares over the past 30 days.

Mettler-Toledo International has a market cap of $5.78 billion and is part of the health care sector and health services industry. Shares are up 27.6% year to date as of the close of trading on Monday.

Mettler-Toledo International Inc. supplies precision instruments and services worldwide. The company has a P/E ratio of 21.6, above the S&P 500 P/E ratio of 17.7.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

TheStreet Ratings rates Mettler-Toledo International as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, notable return on equity, expanding profit margins and good cash flow from operations. Although the company may harbor some minor weaknesses, we feel they are unlikely to have a significant impact on results. You can view the full Mettler-Toledo International Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

Holiday Special: Subscribe to Action Alerts PLUS to see how Jim Cramer trades his $2.5 Million+ portfolio for 51% off the list price. Your first 14-days are FREE: Sign up today to get e-mail alerts before every trade.
null

If you liked this article you might like

PerkinElmer Among Targets Fitting Thermo Fisher's M&A Criteria

Health Care and Pharma Feeling the Wrath of Trump: Cramer's 'Mad Money' Recap (Wednesday 1/11/17)

Berkshire Hathaway, SAP, Dominion Resources: 'Mad Money' Lightning Round

These 5 Health Care Stocks Are Breaking Out This Christmas

Analysts' Actions -- AK Steel, Mettler-Toledo, Pure Storage, Phillips 66 and More